Infectious Disease-Associated Syndromes in the PICU

Chapter

Abstract

In this chapter, we discuss some of the more serious syndromes associated with infectious diseases that are encountered by clinicians in the PICU. The syndromes discussed include necrotizing fasciitis, hemorrhagic shock and encephalopathy, Rocky Mountain spotted fever and Lemierre’s syndrome. All of these conditions are serious, potentially life-threatening syndromes for which early recognition and treatment is critical to obtaining a positive outcome for the patient. We discuss the history and epidemiology, pathogenesis, clinical manifestations and management of each condition with the goal of providing clinicians with the most current information about each syndrome.

Keywords

Necrotizing fasciitis Hemorrhagic shock and encephalopathy Rocky Mountain spotted fever Lemierre’s syndrome Erhlichiosis 

References

  1. 1.
    Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705–10.CrossRefPubMedGoogle Scholar
  2. 2.
    Eneli I, Davies HD. Epidemiology and outcome of necrotizing fasciitis in children: an active surveillance study of the Canadian Paediatric Surveillance Program. J Pediatr. 2007;151(1):79–84. 84 e1.CrossRefPubMedGoogle Scholar
  3. 3.
    Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995;33(9):2382–7.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Pandey A, Gangopadhyay AN, Upadhyaya VD. Necrotising fasciitis in children and neonates: current concepts. J Wound Care. 2008;17(1):5–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Imohl M, et al. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003–2007. FEMS Immunol Med Microbiol. 2010;58(3):389–96.CrossRefPubMedGoogle Scholar
  6. 6.
    O’Loughlin RE, et al. The epidemiology of invasive group a streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis. 2007;45(7):853–62.CrossRefPubMedGoogle Scholar
  7. 7.
    Fustes-Morales A, et al. Necrotizing fasciitis: report of 39 pediatric cases. Arch Dermatol. 2002;138(7):893–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Moss RL, Musemeche CA, Kosloske AM. Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg. 1996;31(8):1142–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Wong CH, Wang YS. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis. 2005;18(2):101–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Jamart S, et al. Methicillin-resistant Staphylococcus aureus toxic shock syndrome. Emerg Infect Dis. 2005;11(4):636–7.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Levin M, et al. Haemorrhagic shock and encephalopathy: a new syndrome with a high mortality in young children. Lancet. 1983;2(8341):64–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Gooskens J, et al. Severe influenza resembling hemorrhagic shock and encephalopathy syndrome. J Clin Virol. 2007;39(2):136–40.CrossRefPubMedGoogle Scholar
  13. 13.
    Lung DC, et al. Hemorrhagic shock and encephalopathy syndrome in a child with pandemic H1N1 2009 influenza virus. Pediatr Infect Dis J. 2011;30(11):998–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Makino M, et al. Haemorrhagic shock and encephalopathy associated with rotavirus infection. Acta Paediatr. 1996;85(5):632–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Sofer S, et al. Hemorrhagic shock and encephalopathy syndrome. Its association with hyperthermia. Am J Dis Child. 1986;140(12):1252–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Levin M, et al. Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr. 1989;114(2):194–203.CrossRefPubMedGoogle Scholar
  17. 17.
    Bacon CJ, et al. Case control study of thermal environment preceding haemorrhagic shock encephalopathy syndrome. Arch Dis Child. 1999;81(2):155–8.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Jardine DS, Winters WD, Shaw DW. CT scan abnormalities in a series of patients with hemorrhagic shock and encephalopathy syndrome. Pediatr Radiol. 1997;27(6):540–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Thebaud B, et al. Haemorrhagic shock and encephalopathy syndrome: neurological course and predictors of outcome. Intensive Care Med. 1999;25(3):293–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Ince E, Kuloglu Z, Akinci Z. Hemorrhagic shock and encephalopathy syndrome: neurologic features. Pediatr Emerg Care. 2000;16(4):260–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Jardine DS, Bratton SL. Using characteristic changes in laboratory values to assist in the diagnosis of hemorrhagic shock and encephalopathy syndrome. Pediatrics. 1995;96(6):1126–31.PubMedGoogle Scholar
  22. 22.
    Nakae H, Asanuma Y, Tajimi K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher. 2002;6(6):419–24.CrossRefPubMedGoogle Scholar
  23. 23.
    Paddock CD, et al. Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources. Am J Trop Med Hyg. 2002;67(4):349–54.PubMedGoogle Scholar
  24. 24.
    Openshaw JJ, et al. Rocky Mountain spotted fever in the United States, 2000–2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg. 2010;83(1):174–82.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Dalton MJ, et al. National surveillance for Rocky Mountain spotted fever, 1981–1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995;52(5):405–13.PubMedGoogle Scholar
  26. 26.
    Buckingham SC, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007;150(2):180–4. 184 e1.CrossRefPubMedGoogle Scholar
  27. 27.
    Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect Dis. 2007;7(11):724–32.CrossRefPubMedGoogle Scholar
  28. 28.
    Dumler JS, Walker DH. Rocky Mountain spotted fever–changing ecology and persisting virulence. N Engl J Med. 2005;353(6):551–3.CrossRefPubMedGoogle Scholar
  29. 29.
    Demma LJ, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med. 2005;353(6):587–94.CrossRefPubMedGoogle Scholar
  30. 30.
    Clifton DR, et al. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha. Infect Immun. 2005;73(1):155–65.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Valbuena G, Walker DH. Changes in the adherens junctions of human endothelial cells infected with spotted fever group rickettsiae. Virchows Arch. 2005;446(4):379–82.CrossRefPubMedGoogle Scholar
  32. 32.
    Razzaq S, Schutze GE. Rocky Mountain spotted fever: a physician’s challenge. Pediatr Rev. 2005;26(4):125–30.CrossRefPubMedGoogle Scholar
  33. 33.
    Centers for Disease Control and Prevention (CDC). Fatal cases of Rocky Mountain spotted fever in family clusters – three states, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:407–10.Google Scholar
  34. 34.
    Consequences of delayed diagnosis of Rocky Mountain spotted fever in children – West Virginia, Michigan, Tennessee, and Oklahoma, May – July 2000, in MMWR Weekly Report. 2000;885–8.Google Scholar
  35. 35.
    Schutze GE. Ehrlichiosis. Pediatr Infect Dis J. 2006;25(1):71–2.CrossRefPubMedGoogle Scholar
  36. 36.
    Lemierre A. On certain septicæmias due to anaerobic organisms. Lancet. 1936;2275874:701–3.CrossRefGoogle Scholar
  37. 37.
    Sinave CP, Hardy GJ, Fardy PW. The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore). 1989;68(2):85–94.CrossRefGoogle Scholar
  38. 38.
    Chirinos JA, et al. The evolution of Lemierre syndrome: report of 2 cases and review of the literature. Medicine (Baltimore). 2002;81(6):458–65.CrossRefGoogle Scholar
  39. 39.
    Williams A, et al. Lemierre syndrome: a complication of acute pharyngitis. Int J Pediatr Otorhinolaryngol. 1998;45(1):51–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Hoehn KS. Lemierre’s syndrome: the controversy of anticoagulation. Pediatrics. 2005;115(5):1415–6.CrossRefPubMedGoogle Scholar
  41. 41.
    Goldenberg NA, et al. Lemierre’s and Lemierre’s-like syndromes in children: survival and thromboembolic outcomes. Pediatrics. 2005;116(4):e543–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Pediatric Intensive Care UnitSoroka Medical CenterBeer ShevaIsrael
  2. 2.Department of PediatricsYale School of MedicineNew HavenUSA

Personalised recommendations